Monsanto’s next generation Acceleron Seed Treatment Products for soybeans and cotton will contain F500-the same active ingredient found in Headline fungicide-and the innovation Xemium fungicide, which is expected to be registered by the US Environmental Protection Agency (EPA) in 2012.
A new generation of the carboxamide class of chemistry, Xemium has shown to provide superior control of key soybean and cotton diseases.
“Growers know that yields can suffer without successful early season crop development,” said Bob Yaklich, market manager for seed solutions for BASF in North America.
“The combination of BASF fungicides, Xemium and F500, provides a new level of disease control, as well as healthier plants and improved crop quality, which can improve yield potential. This new agreement with Monsanto will give growers the opportunity to give seedlings a stronger start and their growing seasons a stronger finish,” Yaklich said.
Under the agreement, Monsanto will have exclusive rights to commercialise the new seed treatments. Monsanto’s global seed treatment platform complements the company’s seed and trait strategy, including its investments in breeding and biotechnology.
Source: Monsanto Company
© FoodBev Media Ltd 2024